SE1 0.00% 0.2¢ sensera limited

Continuous Glucose Monitor, page-83

  1. 238 Posts.
    lightbulb Created with Sketch. 300
    This commentary from Diabeticinvestor is worth a read on Lifescan's positioning in the CGM market:

    https://diabeticinvestor.com/a-path-to/

    Emphasizes the scale of Lifescan's customer base as being vital in the competitive CGM market - all good news for Sensera if we can get that sensor to Sanvita medical.
 
watchlist Created with Sketch. Add SE1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.